Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e396ea175a11a62a6eab085be54656a8 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-107 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D519-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4725 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4709 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-438 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-353 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-06 |
filingDate |
2017-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6c2c92804a679ba91f913e6be323be88 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_37cb8c8aa169237851ded52c2261abd2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6c949b0148a04a1fa1c56b0f8adf35e4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a6c3a797f616e84a4fa016ed046ab32d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_06fae25ee1397a8f91f6e44590220497 |
publicationDate |
2019-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
MX-2019006920-A |
titleOfInvention |
DERIVATIVES OF SPIROPIPERIDINE. |
abstract |
Spiropiperidine compounds according to Formula I are described herein which have shown activity as fatty acid synthase inhibitors. Also disclosed herein are pharmaceutical compositions containing the disclosed spiropiperidine compounds, and methods for treating fatty acid synthase mediated diseases, by administering one or more of the compounds or pharmaceutical formulations disclosed herein. Also described herein are methods for synthesizing the disclosed compounds, including the disclosed spiropiperidine compounds and synthetic intermediates that are useful in such syntheses. (See formula). |
priorityDate |
2016-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |